Polfa Tarchomin expects improved 2003 results

State-owned drugs producer Polfa Tarchomin has announced its intention to improve results and invest over zł. 31 million in 2003. "Exports account for over 40% of our sales, with Eastern markets being our most important ones. This means that we are clearing our transactions in U.S. dollars and consequently every ten grosz drop in the value of the dollar costs our company zł. 3 million," said Polfa Tarchomin president Andrzej Kleszczewski. In 2003 the company expects revenues of zł. 332.4 million, with zł. 107.3 million coming solely from exports. "I expect the revenues to increase by at least 10% in comparison to last year's figures. Most of our clients are hospitals, which have solvency problems," said Kleszczewski. In order to maintain the growth in its sales figures, the company has had to increase its deliveries to retail clients and introduce new medicines. (Puls Biznesu, pp 1, 10) M.M.